Divis Laboratories Ltd | DIVI - Eigenkapital Und Reserven





Eigenkapital Und Reserven Veränderung Datum
Alaunos Therapeutics USD 2.8M 858K 2025-09
Aurobindo Pharma INR 350.34B 23.87B 2025-09
Avita Medical AUD -16.65M 3.76M 2025-12
Dianthus Therapeutics USD 493.4M 53.05M 2025-12
Divis Laboratories Ltd INR 154.13B 4.44B 2025-09
Ionis Pharmaceuticals USD 617.97M 13.76M 2025-09
IQVIA Holdings USD 6.5B 343M 2025-12
Lupin INR 196.33B 23.38B 2025-09
Moderna USD 8.65B 680M 2025-12
Organon & Co USD 906M 173M 2025-09
Revvity USD 7.38B 180.27M 2025-09
Tectonic Therapeutic USD 251.33M 16.2M 2025-12
Tilray USD 1.58B 39.08M 2025-09
Viatris USD 15.22B 352.9M 2025-09
Xeris Pharmaceuticals USD 13.69M 14.55M 2025-12